E mālama ʻia ka CPHI Kina 2025 mai Iune 24-26, 2025, ma ka Shanghai New International Expo Center (SNIEC). ʻOi aku ma mua o 230,000 mau mika square, ua hoʻonohonoho ʻia ka hanana e hoʻokipa ma luna o 3,500 mau mea hōʻikeʻike a hoʻokipa ma mua o 100,000 mau ʻoihana ʻoihana. E like me kekahi o nā hōʻike kālepa lāʻau lapaʻau nui loa a koʻikoʻi o Asia, hāʻawi ʻo CPHI Kina i kahi kahua hoʻohālikelike ʻole no ka ʻupena, hana hou, a me ka hoʻomohala ʻoihana.
 
E pili ana iā JYMed
 
ʻO JYMed kahi hui lāʻau lapaʻau kiʻekiʻe e kālele ana i ka noiʻi, hoʻomohala, hana ʻana, a me ke kālepa ʻana o nā huahana peptide. Hāʻawi pū mākou i nā lawelawe CDMO hoʻohui piha, e hāʻawi ana i nā hoʻonā peptide maʻamau i nā mea kūʻai lāʻau lapaʻau, cosmetic, a me nā holoholona holoholona ma ka honua holoʻokoʻa.
 
Loaʻa i kā mākou waihona huahana he mau haneli o nā API peptide. Ua hoʻopau maikaʻi nā huahana Flagship e like me Semaglutide a me Tirzepatide i ka faila US FDA DMF.

ʻO kā mākou ʻoihana paʻa piha, ʻo Hubei JXBio, e hana ana i nā laina hana peptide API hou i kūkulu ʻia e hoʻokō i nā kūlana cGMP i hoʻonohonoho ʻia e ka US FDA a me ka NMPA o Kina. He 10 mau laina hana nui a me ka pilote, i kākoʻo ʻia e kahi Pūnaehana Manaʻo Kūleʻa Laʻau Paʻa (QMS) a me kahi papahana ʻo Environmental Health and Safety (EHS).
 
Ua hala ʻo JXBio i nā mākaʻikaʻi GMP e ka US FDA a me ka NMPA o Kina a ua ʻike ʻia e ke alakaʻi ʻana i nā hui lāʻau lapaʻau honua no ka maikaʻi o ka hoʻokele EHS, e hōʻike ana i kā mākou kūpaʻa i ka maikaʻi, palekana, a me ka mālama kaiapuni.

HANA NUI

Kāhea iā mā˚ou

No ka ʻike hou aku e pili ana i kā mākou huahana a me nā lawelawe, e ʻoluʻolu e kelepona mai:
● API honua a me nā nīnau hoʻonani:+86-150-1352-9272
● Hoʻopaʻa inoa API a me nā lawelawe CDMO (US & EU):+86-158-1868-2250
● leka uila: jymed@jymedtech.com
● Helu helu:Nā Papa 8 & 9, Hale 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen, Kina.